DNA.TA
Price:
$110
Market Cap:
$135.48M
Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.)...[Read more]
Industry
Biotechnology
IPO Date
2007-12-04
Stock Exchange
TLV
Ticker
DNA.TA
According to Dna Group (T.R.) Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 6.11. This represents a change of -302.28% compared to the average of -3.02 of the last 4 quarters.
The mean historical PE Ratio of Dna Group (T.R.) Ltd over the last ten years is -7.15. The current 6.11 PE Ratio has changed -8641.88% with respect to the historical average. Over the past ten years (40 quarters), DNA.TA's PE Ratio was at its highest in in the March 2023 quarter at 18.83. The PE Ratio was at its lowest in in the June 2025 quarter at -24.26.
Average
-7.15
Median
-1.55
Minimum
-67.80
Maximum
7.43
Discovering the peaks and valleys of Dna Group (T.R.) Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.77%
Maximum Annual PE Ratio = 7.43
Minimum Annual Increase = -732.91%
Minimum Annual PE Ratio = -67.80
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 4.89 | -107.21% |
| 2023 | -67.80 | 1.77% |
| 2022 | -3.63 | -148.77% |
| 2021 | 7.43 | -732.91% |
| 2020 | -1.17 | 166.05% |
| 2019 | -0.44 | -80.58% |
| 2018 | -2.27 | -606.25% |
| 2017 | 0.45 | -106.36% |
| 2016 | -7.06 | 267.84% |
| 2015 | -1.92 | 935.83% |
The current PE Ratio of Dna Group (T.R.) Ltd (DNA.TA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.18
5-year avg
-12.06
10-year avg
-7.15
Dna Group (T.R.) Ltd’s PE Ratio is greater than Geffen Residence & Renewal Ltd (-34.26), greater than G.F.C Green Fields Capital Ltd. (5.18), greater than Golden House Ltd (1.59), greater than Kadimastem Ltd (-1.94), greater than Bonus BioGroup Ltd. (-7.04), greater than Pluri Inc. (-0.88), greater than Enlivex Therapeutics Ltd. (-2.29), greater than Pulsenmore Ltd. (0.09), greater than Rekah Pharmaceutical Industry Ltd. (-9.80), greater than Can-Fite BioPharma Ltd. (-1.20),
| Company | PE Ratio | Market cap |
|---|---|---|
| -34.26 | $177.94M | |
| 5.18 | $136.14M | |
| 1.59 | $176.27M | |
| -1.94 | $125.73M | |
| -7.04 | $300.16M | |
| -0.88 | $76.53M | |
| -2.29 | $96.48M | |
| 0.09 | $135.56M | |
| -9.80 | $133.78M | |
| -1.20 | $51.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dna Group (T.R.) Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dna Group (T.R.) Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Dna Group (T.R.) Ltd's PE Ratio?
How is the PE Ratio calculated for Dna Group (T.R.) Ltd (DNA.TA)?
What is the highest PE Ratio for Dna Group (T.R.) Ltd (DNA.TA)?
What is the 3-year average PE Ratio for Dna Group (T.R.) Ltd (DNA.TA)?
What is the 5-year average PE Ratio for Dna Group (T.R.) Ltd (DNA.TA)?
How does the current PE Ratio for Dna Group (T.R.) Ltd (DNA.TA) compare to its historical average?